ACBI-4 is a selective PROTAC degrader targeting the active state of GTP-loaded KRAS (KRAS(on)). It demonstrates significant antiproliferative effects and effectively degrades various KRAS mutants in cancer cells, such as KRASG12R.
Target:
PROTACs|||Ras
* VAT and and shipping costs not included. Errors and price changes excepted
